• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Oncolytics Biotech Inc

+ Add to Watchlist


1.7000 CAD 0.00000.00%

As of 14:20:34 ET on 04/24/2014.

Snapshot for Oncolytics Biotech Inc (ONC)

Open: 1.7000 Day's Range: 1.6800 - 1.7200 Volume: 17,164
Previous Close: 1.7000 52wk Range: 1.5400 - 3.6200 1-Yr Rtn: -44.81%

Stock Chart for ONC

No chart data available.
  • ONC:CN 1.7000
  • 1D
  • 1M
  • 1Y
Interactive ONC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ONC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.2780
Est. EPS (CAD) (12/2014) -0.3020
Est. PEG Ratio -
Market Cap (M CAD) 144.17
Shares Outstanding (M) 84.80
30 Day Average Volume 88,034
Price/Book (mrq) 5.2139
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ONC

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ONC

Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.

Bradley G Thompson "Brad"Chairman/President/CEOKirk LookChief Financial Officer
Matthew C Coffey "Matt"COO/Co-FounderAlan J TuchmanSenior VP:Clinical/Chief Medical Ofcr
More Company Profile & Key Executives for ONC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil